APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amphetamine Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Amphetamine Drug Industry Growth and Trends Forecast to 2032

2 January 202692 pages

Choose your research edition.

Industry ResearchAmphetamine Drug Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Amphetamine Drug Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Amphetamine Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amphetamine Drug Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Amphetamine Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Amphetamine Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Amphetamine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Amphetamine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amphetamine Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Amphetamine Drug include Novartis, Eli Lilly, Pfizer, GSK, Purdue Pharma and Hisamitsu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Amphetamine Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Amphetamine Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Amphetamine Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Amphetamine Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Amphetamine Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Amphetamine Drug Market by Company

Novartis

Eli Lilly

Pfizer

GSK

Purdue Pharma

Hisamitsu Pharmaceutical

Amphetamine Drug Segment by Type

Adult

Children

Amphetamine Drug Segment by Application

Retail Pharmacy

Hospital Pharmacy

Other

Amphetamine Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amphetamine Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amphetamine Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amphetamine Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Amphetamine Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Amphetamine Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Adult Table 2. Major Company of Children Table 3. Global Amphetamine Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Amphetamine Drug Sales by Type (2021-2026) & (K Units) Table 5. Global Amphetamine Drug Sales Market Share in Volume by Type (2021-2026) Table 6. Global Amphetamine Drug Sales by Type (2021-2026) & (US$ Million) Table 7. Global Amphetamine Drug Sales Market Share in Value by Type (2021-2026) Table 8. Global Amphetamine Drug Price by Type (2021-2026) & (US$/Unit) Table 9. Global Amphetamine Drug Sales by Type (2027-2032) & (K Units) Table 10. Global Amphetamine Drug Sales Market Share in Volume by Type (2027-2032) Table 11. Global Amphetamine Drug Sales by Type (2027-2032) & (US$ Million) Table 12. Global Amphetamine Drug Sales Market Share in Value by Type (2027-2032) Table 13. Global Amphetamine Drug Price by Type (2027-2032) & (US$/Unit) Table 14. North America Amphetamine Drug Sales by Type (2021-2026) & (K Units) Table 15. North America Amphetamine Drug Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Amphetamine Drug Sales by Type (2021-2026) & (K Units) Table 17. Europe Amphetamine Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Amphetamine Drug Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Amphetamine Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Amphetamine Drug Sales by Type (2021-2026) & (K Units) Table 21. Latin America Amphetamine Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Amphetamine Drug Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Amphetamine Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Amphetamine Drug Industry Trends Table 25. Amphetamine Drug Industry Drivers Table 26. Amphetamine Drug Industry Opportunities and Challenges Table 27. Amphetamine Drug Industry Restraints Table 28. Global Amphetamine Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Amphetamine Drug Revenue Market Share by Company (2021-2026) Table 30. Global Amphetamine Drug Sales by Company (2021-2026) & (K Units) Table 31. Global Amphetamine Drug Sales Share by Company (2021-2026) Table 32. Global Amphetamine Drug Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Amphetamine Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Amphetamine Drug Major Company Production Sites and Headquarters Table 35. Global Amphetamine Drug Company, Product Type & Application Table 36. Global Amphetamine Drug Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Amphetamine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Amphetamine Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Amphetamine Drug Sales by Region (2021-2026) & (K Units) Table 41. Global Amphetamine Drug Sales Market Share in Volume by Region (2021-2026) Table 42. Global Amphetamine Drug Sales by Region (2021-2026) & (US$ Million) Table 43. Global Amphetamine Drug Sales Market Share in Value by Region (2021-2026) Table 44. Global Amphetamine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Amphetamine Drug Sales by Region (2027-2032) & (K Units) Table 46. Global Amphetamine Drug Sales Market Share in Volume by Region (2027-2032) Table 47. Global Amphetamine Drug Sales by Region (2027-2032) & (US$ Million) Table 48. Global Amphetamine Drug Sales Market Share in Value by Region (2027-2032) Table 49. Global Amphetamine Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Amphetamine Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Amphetamine Drug Sales by Application (2021-2026) & (K Units) Table 52. Global Amphetamine Drug Sales Market Share in Volume by Application (2021-2026) Table 53. Global Amphetamine Drug Sales by Application (2021-2026) & (US$ Million) Table 54. Global Amphetamine Drug Sales Market Share in Value by Application (2021-2026) Table 55. Global Amphetamine Drug Price by Application (2021-2026) & (US$/Unit) Table 56. Global Amphetamine Drug Sales by Application (2027-2032) & (K Units) Table 57. Global Amphetamine Drug Sales Market Share in Volume by Application (2027-2032) Table 58. Global Amphetamine Drug Sales by Application (2027-2032) & (US$ Million) Table 59. Global Amphetamine Drug Sales Market Share in Value by Application (2027-2032) Table 60. Global Amphetamine Drug Price by Application (2027-2032) & (US$/Unit) Table 61. North America Amphetamine Drug Sales by Application (2021-2026) & (K Units) Table 62. North America Amphetamine Drug Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Amphetamine Drug Sales by Application (2021-2026) & (K Units) Table 64. Europe Amphetamine Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Amphetamine Drug Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Amphetamine Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Amphetamine Drug Sales by Application (2021-2026) & (K Units) Table 68. Latin America Amphetamine Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Amphetamine Drug Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Amphetamine Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Novartis Amphetamine Drug Product Portfolio Table 75. Novartis Recent Development Table 76. Eli Lilly Company Information Table 77. Eli Lilly Business Overview Table 78. Eli Lilly Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Eli Lilly Amphetamine Drug Product Portfolio Table 80. Eli Lilly Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer Amphetamine Drug Product Portfolio Table 85. Pfizer Recent Development Table 86. GSK Company Information Table 87. GSK Business Overview Table 88. GSK Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. GSK Amphetamine Drug Product Portfolio Table 90. GSK Recent Development Table 91. Purdue Pharma Company Information Table 92. Purdue Pharma Business Overview Table 93. Purdue Pharma Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Purdue Pharma Amphetamine Drug Product Portfolio Table 95. Purdue Pharma Recent Development Table 96. Hisamitsu Pharmaceutical Company Information Table 97. Hisamitsu Pharmaceutical Business Overview Table 98. Hisamitsu Pharmaceutical Amphetamine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Hisamitsu Pharmaceutical Amphetamine Drug Product Portfolio Table 100. Hisamitsu Pharmaceutical Recent Development Table 101. North America Amphetamine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Amphetamine Drug Sales by Country (2021-2026) & (K Units) Table 103. North America Amphetamine Drug Sales Market Share by Country (2021-2026) Table 104. North America Amphetamine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Amphetamine Drug Sales Market Share Forecast by Country (2027-2032) Table 106. North America Amphetamine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Amphetamine Drug Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Amphetamine Drug Market Share by Country (2021-2026) Table 109. North America Amphetamine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Amphetamine Drug Market Share Forecast by Country (2027-2032) Table 111. Europe Amphetamine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Amphetamine Drug Sales by Country (2021-2026) & (K Units) Table 113. Europe Amphetamine Drug Sales Market Share by Country (2021-2026) Table 114. Europe Amphetamine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Amphetamine Drug Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Amphetamine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Amphetamine Drug Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Amphetamine Drug Market Share by Country (2021-2026) Table 119. Europe Amphetamine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Amphetamine Drug Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Amphetamine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Amphetamine Drug Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Amphetamine Drug Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Amphetamine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Amphetamine Drug Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Amphetamine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Amphetamine Drug Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Amphetamine Drug Market Share by Country (2021-2026) Table 129. Asia-Pacific Amphetamine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Amphetamine Drug Market Share Forecast by Country (2027-2032) Table 131. Latin America Amphetamine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Amphetamine Drug Sales by Country (2021-2026) & (K Units) Table 133. Latin America Amphetamine Drug Sales Market Share by Country (2021-2026) Table 134. Latin America Amphetamine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Amphetamine Drug Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Amphetamine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Amphetamine Drug Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Amphetamine Drug Market Share by Country (2021-2026) Table 139. Latin America Amphetamine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Amphetamine Drug Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Amphetamine Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Amphetamine Drug Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Amphetamine Drug Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Amphetamine Drug Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Amphetamine Drug Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Amphetamine Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Amphetamine Drug Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Amphetamine Drug Market Share by Country (2021-2026) Table 149. Middle East and Africa Amphetamine Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Amphetamine Drug Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Amphetamine Drug Distributors List Table 154. Amphetamine Drug Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Amphetamine Drug Image Figure 2. Global Amphetamine Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amphetamine Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Amphetamine Drug Sales (2021-2032) & (K Units) Figure 5. Adult Image Figure 6. Global Adult Sales YoY Growth (2021-2032) & (K Units) Figure 7. Children Image Figure 8. Global Children Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Amphetamine Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Amphetamine Drug Market Share by Type 2025 VS 2032 Figure 11. North America Amphetamine Drug Sales Market Share in Volume by Type in 2025 Figure 12. North America Amphetamine Drug Sales Market Share in Value by Type in 2025 Figure 13. Europe Amphetamine Drug Sales Market Share in Volume by Type in 2025 Figure 14. Europe Amphetamine Drug Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Amphetamine Drug Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Amphetamine Drug Sales Market Share in Value by Type in 2025 Figure 17. Latin America Amphetamine Drug Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Amphetamine Drug Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Amphetamine Drug Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Amphetamine Drug Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Amphetamine Drug Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Retail Pharmacy Image Figure 24. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospital Pharmacy Image Figure 26. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Amphetamine Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Amphetamine Drug Market Share by Application 2025 VS 2032 Figure 31. North America Amphetamine Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Amphetamine Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Amphetamine Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Amphetamine Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Amphetamine Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Amphetamine Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Amphetamine Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Amphetamine Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Amphetamine Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Amphetamine Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Amphetamine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Amphetamine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Amphetamine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Amphetamine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Amphetamine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Amphetamine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Amphetamine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Amphetamine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Amphetamine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Amphetamine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Amphetamine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Amphetamine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Amphetamine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Amphetamine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Amphetamine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Amphetamine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Amphetamine Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Amphetamine Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Amphetamine Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Amphetamine Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Amphetamine Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Amphetamine Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Adult
  • Children
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Other
Companies covered
  • Novartis
  • Eli Lilly
  • Pfizer
  • GSK
  • Purdue Pharma
  • Hisamitsu Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amphetamine Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Amphetamine Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Amphetamine Drug Market by Type
  6. 1.3.1 Adult
  7. 1.3.2 Children
  8. 1.4 Global Amphetamine Drug Market Size by Type
  9. 1.4.1 Global Amphetamine Drug Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Amphetamine Drug Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Amphetamine Drug Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Amphetamine Drug Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Amphetamine Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Amphetamine Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Amphetamine Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Amphetamine Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Amphetamine Drug Industry Trends
  2. 2.2 Amphetamine Drug Industry Drivers
  3. 2.3 Amphetamine Drug Industry Opportunities and Challenges
  4. 2.4 Amphetamine Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Amphetamine Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Amphetamine Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Amphetamine Drug Price (2021-2026)
  4. 3.4 Global Amphetamine Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Amphetamine Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Amphetamine Drug Company, Product Type & Application
  7. 3.7 Global Amphetamine Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Amphetamine Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Amphetamine Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Amphetamine Drug Tier 1, Tier 2, and Tier 3
4 Amphetamine Drug Regional Status and Outlook
  1. 4.1 Global Amphetamine Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Amphetamine Drug Historic Market Size by Region
  3. 4.2.1 Global Amphetamine Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Amphetamine Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Amphetamine Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Amphetamine Drug Forecasted Market Size by Region
  7. 4.3.1 Global Amphetamine Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Amphetamine Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Amphetamine Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Amphetamine Drug by Application
  1. 5.1 Amphetamine Drug Market by Application
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Amphetamine Drug Market Size by Application
  6. 5.2.1 Global Amphetamine Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Amphetamine Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Amphetamine Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Amphetamine Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Amphetamine Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Amphetamine Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Amphetamine Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Amphetamine Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Amphetamine Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Amphetamine Drug Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Eli Lilly
  8. 6.2.1 Eli Lilly Company Information
  9. 6.2.2 Eli Lilly Business Overview
  10. 6.2.3 Eli Lilly Amphetamine Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eli Lilly Amphetamine Drug Product Portfolio
  12. 6.2.5 Eli Lilly Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Amphetamine Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Amphetamine Drug Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 GSK
  20. 6.4.1 GSK Company Information
  21. 6.4.2 GSK Business Overview
  22. 6.4.3 GSK Amphetamine Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GSK Amphetamine Drug Product Portfolio
  24. 6.4.5 GSK Recent Developments
  25. 6.5 Purdue Pharma
  26. 6.5.1 Purdue Pharma Company Information
  27. 6.5.2 Purdue Pharma Business Overview
  28. 6.5.3 Purdue Pharma Amphetamine Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Purdue Pharma Amphetamine Drug Product Portfolio
  30. 6.5.5 Purdue Pharma Recent Developments
  31. 6.6 Hisamitsu Pharmaceutical
  32. 6.6.1 Hisamitsu Pharmaceutical Company Information
  33. 6.6.2 Hisamitsu Pharmaceutical Business Overview
  34. 6.6.3 Hisamitsu Pharmaceutical Amphetamine Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hisamitsu Pharmaceutical Amphetamine Drug Product Portfolio
  36. 6.6.5 Hisamitsu Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Amphetamine Drug Sales by Country
  2. 7.1.1 North America Amphetamine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Amphetamine Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Amphetamine Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Amphetamine Drug Market Size by Country
  6. 7.2.1 North America Amphetamine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Amphetamine Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Amphetamine Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Amphetamine Drug Sales by Country
  2. 8.1.1 Europe Amphetamine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Amphetamine Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Amphetamine Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Amphetamine Drug Market Size by Country
  6. 8.2.1 Europe Amphetamine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Amphetamine Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Amphetamine Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Amphetamine Drug Sales by Country
  2. 9.1.1 Asia-Pacific Amphetamine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Amphetamine Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Amphetamine Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Amphetamine Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Amphetamine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Amphetamine Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Amphetamine Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Amphetamine Drug Sales by Country
  2. 10.1.1 South America Amphetamine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Amphetamine Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Amphetamine Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Amphetamine Drug Market Size by Country
  6. 10.2.1 South America Amphetamine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Amphetamine Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Amphetamine Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Amphetamine Drug Sales by Country
  2. 11.1.1 Middle East and Africa Amphetamine Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Amphetamine Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Amphetamine Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Amphetamine Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Amphetamine Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Amphetamine Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Amphetamine Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Amphetamine Drug Value Chain Analysis
  2. 12.1.1 Amphetamine Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Amphetamine Drug Production Mode & Process
  7. 12.2 Amphetamine Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Amphetamine Drug Distributors
  10. 12.2.3 Amphetamine Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst